Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc
(NY:
BHC
)
8.270
+0.110 (+1.35%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch Health Companies Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...
Via
Benzinga
Why Bausch Health Companies Stock Zoomed 8% Higher Today
September 21, 2021
One analyst crunches the numbers to come up with a share price valuation well above current levels.
Via
The Motley Fool
NYSE: BHC Shareholder Notice: Investigation over Potential Wrongdoing at Bausch Health Companies Inc.
September 13, 2021
San Diego, CA -- (SBWIRE) -- 09/13/2021 -- An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing at Bausch Health Companies Inc. was...
Via
SBWire
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Bausch Pays $300M For Diabetes Drug Lawsuit: Reuters
September 10, 2021
Reuters reports that Bausch Health Companies Inc (NYSE: BHC) will pay $300 million to settle an antitrust lawsuit related to illegally maintaining a monopoly on...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Unusual Options Activity Insight: Bausch Health Companies
August 06, 2021
Bausch Health Companies (NYSE:BHC) shares experienced unusual...
Via
Benzinga
Unusual Options Activity Insight: Bausch Health Companies
August 04, 2021
Bausch Health Companies (NYSE:BHC) shares experienced unusua...
Via
Benzinga
Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
August 17, 2021
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and...
Via
Benzinga
Bausch Health Companies Inc. (NYSE:BHC) Investor Notice: Investigation over Possible Violations of Securities Laws
August 16, 2021
San Diego, CA -- (SBWIRE) -- 08/16/2021 -- Bausch Health Companies Inc is under investigation over potential securities laws in connection with certain financial statements.
Via
SBWire
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
75 Biggest Movers From Yesterday
August 04, 2021
Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a...
Via
Benzinga
Why Bausch Health Companies Is Plunging Today
August 03, 2021
The turnaround isn't happening as fast as investors expected.
Via
The Motley Fool
Topics
Product Recall
Exposures
Legal
Product Safety
Bausch Health Companies inc (BHC) Q2 2021 Earnings Call Transcript
August 03, 2021
BHC earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
48 Stocks Moving In Tuesday's Mid-Day Session
August 03, 2021
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 64.4% to $7.15 after a Form 4 filing from the company showed 10% shareholder Retail Ecommerce Ventures...
Via
Benzinga
Bausch Health Misses On Q2 Sales, Cuts FY21 Outlook, Plans IPO For Medical Aesthetics Business
August 03, 2021
Bausch Health Companies Inc (NYSE: BHC) has reported Q2 revenues of $2.1 billion, +26% Y/Y, and missing the consensus of $2.12 billion. Revenue increased organically by...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Earnings Outlook For Bausch Health Companies
August 02, 2021
Bausch Health Companies (NYSE:BHC) releases its next round of earnings this Tuesday, August 03. Here is Benzinga's essential guide to Bausch Health Companies's Q2 earnings report...
Via
Benzinga
Unusual Options Activity Insight: Bausch Health Companies
July 28, 2021
Shares of Bausch Health Companies (NYSE:BHC) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $28.94. Sentiment:...
Via
Benzinga
Analyzing Bausch Health Companies's Unusual Options Activity
July 15, 2021
On Thursday, shares of Bausch Health Companies (NYSE:BHC) saw unusual options activity. After the option alert, the stock price moved down to $28.52. Sentiment: BEARISH Option...
Via
Benzinga
New Month And Half Year
July 01, 2021
Welcome to H2. In theory, if markets did well in H1 they tend to close the year up.
Via
Talk Markets
Reconsidered Boom
June 22, 2021
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded.
Via
Talk Markets
Charles River's Jim Foster Beat The Trauma Of Being CEO
June 10, 2021
Think taking over the family business is easy? Charles River CEO Jim Foster might beg to differ. He's shown that being CEO comes with trauma.
Via
Investor's Business Daily
Fan Hit
June 03, 2021
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares.
Via
Talk Markets
The 3 Best Stocks to Buy for Summer 2021
June 03, 2021
Looking for huge winners over the long run? Here are three top picks.
Via
The Motley Fool
Good Times For Gold
May 26, 2021
Gold is rising some more, in part as an alternative to crypto.
Via
Talk Markets
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
May 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...
Via
Benzinga
Exposures
COVID-19
Worldwide Upbeat
May 21, 2021
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
May 18, 2021
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and...
Via
Benzinga
2 Top Turnaround Stocks to Buy Now
May 05, 2021
These two battered stocks have reignited investors' passion over the past year. Can their momentum last?
Via
The Motley Fool
64 Biggest Movers From Yesterday
May 05, 2021
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...
Via
Benzinga
Exposures
COVID-19
44 Stocks Moving In Tuesday's Mid-Day Session
May 04, 2021
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target...
Via
Benzinga
Exposures
COVID-19
Why Bausch Health Stock Is Falling Today
May 04, 2021
The company's mixed Q1 results are partially to blame.
Via
The Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.